MTF-hERG:一个基于融合的多类型特征框架,用于预测hERG化合物的心脏毒性.
IEEE transactions on computational biology and bioinformatics
|September 25, 2025
概括
一个新的深度学习模型,MTF-hERG,通过融合分子特征,准确地预测人类以太-a-go-go相关基因 (hERG) 心脏毒性. 这通过早期识别潜在的hERG阻断剂来提高药物开发效率和安全性.
科学领域:
- 计算化学和毒理学计算化学和毒理学
- 药理学和药物发现
- 医学中的人工智能
背景情况:
- 人类以太-a-go-go相关基因 (hERG) 通道抑制会导致危及生命的心律失常.
- 准确预测hERG心脏毒性对于安全的药物开发至关重要.
- 传统的毒性评估耗时且产量低.
研究的目的:
- 开发一种新的深度学习框架,MTF-hERG,用于准确预测hERG心脏毒性.
- 提高药物开发效率,降低与hERG通道阻断剂相关的风险.
主要方法:
- 提出了一个多类型的特征融合框架 (MTF-hERG),集成分子指纹,2D图像和3D图形.
- 使用完全连接的神经网络,DenseNet和等价图形神经网络来提取特征.
- 利用深度特征融合和完全连接的层来对hERG活动进行分类和回归预测.
主要成果:
- MTF-hERG实现了高平均绩效指标:ACC (0.926),AUC (0.943),AUPR (0.913),RMSE (0.453) 和R2 (0.681).这些指标均为ACC (0.926),AUC (0.943),AUPR (0.913),RMSE (0.453) 和R2 (0.681) 的平均绩效指标.
- 该模型在基准数据集上显著优于现有的最先进方法.
- 视觉化揭示了关键的预测特征和决策机制,有助于分子结构的优化.
结论:
- 该MTF-hERG框架显示了对hERG心脏毒性的优异预测性能.
- 该工具为药物开发提供了强有力的支持,提高了安全性和效率.
- MTF-hERG有可能对药物发现和个性化医学产生重大影响.
相关概念视频
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
4.0K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.0K
01:27Combined Effects of Drugs: Synergism
6.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.8K
01:25Mutagenicity and Carcinogenicity
1.9K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.9K